M72.8
Other fibroblastic disorders
Clinical Classification Guidelines
Use Additional Code
- code to (B95.-, B96.-) identify causative organism
Inclusion Terms
- Abscess of fascia
- Fasciitis NEC
- Other infective fasciitis
Excludes Type 1
- diffuse (eosinophilic) fasciitis (M35.4)
- necrotizing fasciitis (M72.6)
- nodular fasciitis (M72.4)
- perirenal fasciitis NOS (N13.5)
- perirenal fasciitis with infection (N13.6)
- plantar fasciitis (M72.2)
Medical Intelligence & Overview
ICD-10 code M72.8 refers to a group of conditions categorized as other fibroblastic disorders. These involve abnormal growths or changes in fibroblast cells, which are vital components of connective tissue. While this code encompasses various disorders, it also includes specific conditions such as abscesses of fascia and certain forms of fasciitis that are not classified elsewhere. These diseases typically affect the tissues surrounding muscles and other structures, leading to inflammation, swelling, and potential complications if not appropriately managed.
Causes & Symptoms
Clinical Causes: The causes of other fibroblastic disorders can vary based on the specific condition. In the case of infections like fasciitis, causes include: - Bacterial infections (commonly Staphylococcus or Streptococcus species) - Fungal infections in immunocompromised individuals - Traumatic injuries that introduce pathogens or damage tissue - Spread of infection from nearby areas For non-infective fibroblastic disorders, causes may involve: - Genetic factors influencing cell growth - Abnormal responses to injury or inflammation - Exposure to certain chemicals or environmental agents - Chronic immune responses leading to tissue changes
Key Symptoms: Patients with fibroblastic disorders may experience diverse symptoms depending on the specific condition and severity. Common symptoms include: - Swelling and firmness in affected areas - Pain or tenderness, especially with movement or touch - Redness and warmth over the affected tissue - Limited range of motion if joints or tissues are involved - Fever and systemic symptoms in cases of infection - Formation of abscesses presenting as localized lumps filled with pus In fasciitis, symptoms can include rapid swelling, severe pain out of proportion to initial injury, and sometimes skin discoloration.
Diagnostic & Treatment
Diagnosis Path: To accurately identify these disorders, healthcare providers may utilize various diagnostic tools, such as: - Physical examination focusing on swelling, warmth, and tenderness - Imaging studies, including MRI or ultrasound, to visualize tissue changes or abscesses - Blood tests to detect signs of infection or inflammation - Aspiration or biopsy of the affected tissue to identify causative agents or cellular characteristics - Culture tests to determine bacterial or fungal pathogens if infection is suspected These assessments help differentiate between infectious and non-infectious fibroblastic conditions, guiding appropriate management.
Treatment Protocols: Treatment options for fibrous disorders depend on the underlying cause and severity. Common approaches include: - Antibiotic therapy for bacterial infections - Antifungal medications if a fungal infection is identified - Surgical drainage of abscesses to remove pus and reduce tissue pressure - Anti-inflammatory drugs to manage inflammation and pain - Physical therapy to maintain or restore function in affected areas - In some cases, surgical removal of abnormal fibroblastic tissue may be considered - Supportive care, including pain management and rest, during recovery It is essential for treatment to be tailored to each individual's specific diagnosis and health status, under medical supervision.
Clinical Advice & FAQs
Billing Guidance
Is M72.8 a billable ICD-10 code?
Yes, M72.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M72.8?
Clinical documentation must specify the nature of Other fibroblastic disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
